News

Niu Technologies Announced Strong Growth Amid Market Challenges

Niu Technologies Announced Strong Growth Amid Market Challenges

The Rising Success of Niu Technologies

Chinese electric scooter manufacturer Niu Technologies (NASDAQ: NIU) has recently seen a notable rise in its stock price, signaling positive market sentiment after the company revealed its impressive third-quarter financial performance.

Spectacular Revenue Growth

The company reported a remarkable 65.4% year-over-year revenue increase, amounting to approximately $237.94 million (1.69 billion Chinese yuan). This growth was largely fueled by a 49.1% boost in the volume of e-scooter sales and an 11.0% rise in revenue generated per unit sold.

Adjusted Earnings Prosper

Niu's adjusted earnings per share (EPADS) improved significantly to 14 cents, a reversal from a loss of 7 cents reported in the same quarter last year, demonstrating improved profitability.

Sales Volume Highlights

In total, Niu sold 465,873 e-scooters during the quarter, reflecting a robust 49.1% growth compared to the previous year. Out of this total, 451,455 units were sold in the domestic Chinese market, representing a staggering 74.2% increase year-over-year.

International Market Performance

Conversely, the international sales exhibited a decline, with only 14,418 e-scooters sold, down 73.0% from the previous year. This decline reflects market challenges faced outside of China.

Robust Franchise Expansion

By the end of September 2025, Niu had successfully established a network of 4,542 franchised stores in China. Furthermore, the company’s international sales infrastructure had expanded to include 57 distributors across 53 countries, illustrating their ambition to expand globally.

Revenue Breakdown from Markets

Sales in the China market accounted for a substantial 1.48 billion Chinese yuan, which is an impressive growth of 85.8% year-over-year, contributing about 95.7% to the total e-scooter revenue. This surge is attributed to the combination of higher sales volume and increased revenue per unit.

International revenues, however, showed a contrasting trend with sales amounting to only 67.0 million Chinese yuan, marking a significant decrease of 48.6% year-over-year. This decline is largely due to lower sales and pricing pressures experienced in the international markets.

Accessory and Service Growth

Niu also reported solid growth in accessories, spare parts, and services, with revenues reaching 145.0 million Chinese yuan, which translates to a 50.8% year-over-year increase. This segment now represents 8.6% of the total revenues, indicating stronger demand for these additional offerings within China.

Financial Stability and Future Outlook

The company maintains a strong financial position, with 1.58 billion Chinese yuan in cash and equivalents as of the end of September 2025, suggesting a sound liquidity position to support future growth strategies.

Looking ahead, Niu's CEO, Dr. Yan Li, expressed optimism regarding the prospects for the remainder of the year, particularly noting the company’s ability to leverage its competitive product offerings and store expansion plans to navigate the seasonal fluctuations typically seen in the fourth quarter.

Projected Fourth Quarter Earnings

Niu has forecasted its fourth-quarter revenue to fall between 737 million Chinese yuan and 901 million Chinese yuan. This represents an anticipated change of between -10% to +10% compared to the previous year, reflecting their cautious but strategic approach to market conditions.

Current Market Performance

In recent trading, shares of NIU saw an uptick of 8.74%, bringing the price to approximately $4.230 during premarket activity. This surge reflects renewed investor interest in the company following the release of its favorable financial results.

Frequently Asked Questions

What were Niu Technology's third-quarter results?

Niu reported a 65.4% increase in revenue to $237.94 million, with an adjusted EPADS of 14 cents.

How many e-scooters did Niu sell?

Niu sold a total of 465,873 e-scooters, a growth of 49.1% year-over-year.

What markets showed growth for Niu?

The domestic Chinese market showed significant growth, increasing sales by 74.2% year-over-year.

What is Niu's financial position?

The company holds 1.58 billion Chinese yuan in cash and equivalents, indicating financial stability.

What is the forecast for Niu's fourth quarter?

Niu anticipates fourth-quarter revenue between 737 million and 901 million Chinese yuan, a year-over-year estimate of -10% to +10%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 111

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 74

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 18

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Reviving Carbide Tools: Resharpening for Cost Control

Updated Category News Views 52

Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 65

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Bioactive Research: Converting Science into Guidance

Updated Category News Views 0

Unlocking the Science of Dietary Bioactives Amidst a world swimming in kale smoothies and exotic teas, ILSI U.S. & Canada gathered the sharpest minds to discuss dietary bioactives, an area once shrugged off but now coming into its own. On October 28, 2026, over 250 folks from government, academia, and industry tuned in, looking to understand how these compounds, found in...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 82

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading